Citadel Advisors’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,600
| Closed | -$110K | – | 14951 |
|
|
2025
Q1 | $110K | Sell |
3,600
-1,000
| -22% | -$33.7K | ﹤0.01% | 11329 |
|
|
2024
Q4 | $182K | Buy |
4,600
+3,200
| +229% | +$124K | ﹤0.01% | 10598 |
|
|
2024
Q3 | $54.3K | Buy |
1,400
+900
| +180% | +$36.4K | ﹤0.01% | 11816 |
|
|
2024
Q2 | $21K | Buy |
500
+300
| +150% | +$10.2K | ﹤0.01% | 12592 |
|
|
2024
Q1 | $5.87K | Buy |
200
+100
| +100% | +$3.19K | ﹤0.01% | 13720 |
|
|
2023
Q4 | $3.63K | Sell |
100
-300
| -75% | -$9.83K | ﹤0.01% | 13572 |
|
|
2023
Q3 | $12.8K | Sell |
400
-2,300
| -85% | -$78.1K | ﹤0.01% | 12946 |
|
|
2023
Q2 | $84.5K | Sell |
2,700
-5,800
| -68% | -$132K | ﹤0.01% | 11176 |
|
|
2023
Q1 | $194K | Buy |
8,500
+3,300
| +63% | +$85K | ﹤0.01% | 10243 |
|
|
2022
Q4 | $177K | Buy |
+5,200
| New | +$174K | ﹤0.01% | 10351 |
|
|
2019
Q3 | – | Sell |
-5,100
| Closed | -$220K | – | 9720 |
|
|
2019
Q2 | $220K | Buy |
+5,100
| New | +$215K | ﹤0.01% | 8057 |
|
|
2019
Q1 | – | Sell |
-13,000
| Closed | -$614K | – | 9845 |
|
|
2018
Q4 | $614K | Sell |
13,000
-8,400
| -39% | -$504K | ﹤0.01% | 6091 |
|
|
2018
Q3 | $1.6M | Buy |
21,400
+16,600
| +346% | +$1.14M | ﹤0.01% | 4765 |
|
|
2018
Q2 | $265K | Buy |
+4,800
| New | +$222K | ﹤0.01% | 7419 |
|
|
2015
Q4 | – | Sell |
-1,300
| Closed | -$28K | – | 9172 |
|
|
2015
Q3 | $28K | Sell |
1,300
-1,200
| -48% | -$28.2K | ﹤0.01% | 7970 |
|
|
2015
Q2 | $59K | Buy |
2,500
+600
| +32% | +$15.1K | ﹤0.01% | 7553 |
|
|
2015
Q1 | $49K | Sell |
1,900
-1,500
| -44% | -$35.7K | ﹤0.01% | 7395 |
|
|
2014
Q4 | $75K | Buy |
3,400
+2,200
| +183% | +$46.6K | ﹤0.01% | 6900 |
|
|
2014
Q3 | $22K | Sell |
1,200
-800
| -40% | -$16K | ﹤0.01% | 7361 |
|
|
2014
Q2 | $43K | Sell |
2,000
-800
| -29% | -$17.1K | ﹤0.01% | 6858 |
|
|
2014
Q1 | $63K | Buy |
2,800
+200
| +8% | +$4.88K | ﹤0.01% | 6576 |
|
|
2013
Q4 | $63K | Sell |
2,600
-1,400
| -35% | -$33K | ﹤0.01% | 5911 |
|
|
2013
Q3 | $95K | Buy |
4,000
+3,200
| +400% | +$68.6K | ﹤0.01% | 5386 |
|
|
2013
Q2 | $16K | Buy |
+800
| New | +$20K | ﹤0.01% | 6124 |
|
Other funds holding SRDX
Citadel Advisors's SRDX Position: Q4 2025 in Review
Citadel Advisors sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 365,110 shares — an estimated $10.9M sold.
Citadel Advisors first reported a position in SRDX in Q2 2013 and held it in 42 quarters. The position peaked at $10.9M in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Citadel Advisors reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 365,110 Surmodics shares in Q4 2025, an estimated $10.9M.
- Citadel Advisors first reported a position in Surmodics in Q2 2013 and held it in 42 quarters.
- Citadel Advisors's Surmodics position peaked at $10.9M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.